When Factor VIII/von Willebrand factor (FVIII/vWF) protein is rechromatographed on 4% agarose in 0.25 M CaCl2, the protein and vWF activity appear in the void volume, but most of the FVIII procoagulant activity elutes later. Recent evidence suggests that the delayed FVIII procoagulant activity is a proteolytically modified form of FVIII/vWF protein that filters anomalously from agarose in 0.25 M CaCl2. To test whether or not thrombin is the protease involved, the effect of 0.25 M CaCl2 on FVIII/vWF and its reaction with thrombin was examined. About 30% of the FVIII procoagulant activity was lost immediately when solutions of FVIII/vWF protein were made 0.25 M in CaCl2. When FVIII in 0.15 M NaCl was activated with 0.04 U thrombin/ml and then made 0.25 M in CaCl2, the procoagulant activity of a broad range of FVIII/vWF protein concentrations remained activated for at least 6 h. But, in 0.25 M CaCl2, the increase in FVIII procoagulant activity in response to thrombin was much more gradual and once activated, the procoagulant activity was stabilized by 0.25 M CaCl2. When thrombin-activated FVIII/vWF protein was filtered on 4% agarose in 0.15 M NaCl, there was considerable inactivation of FVIII procoagulant activity; however, the procoagulant activity that did remain eluted in the void volume. In contrast, when thrombin-activated FVIII/vWF protein was filtered in 0.25 M CaCl2, the FVIII procoagulant activity eluted well after the void volume and remained activated for 6 h. The procoagulant peak isolated by filtering nonthrombin-activated FVIII/vWF protein on agarose in 0.25 M CaCl2 was compared to that isolated from thrombin-activated FVIII/vWF protein. Both procoagulant activity peak proteins had about the same specific vWF activity as the corresponding void volume protein. Before reduction, the sodium dodecyl sulfate gel patterns for the two procoagulant activity peak proteins were the same. After reduction, the gel pattern for the nonthrombin-activated procoagulant activity peak protein contained bands of 195,000, 148,000-120,000, 79,000, 61,000, 51,000, and 18,000 daltons whereas the pattern for the reduced thrombin-activated procoagulant activity peak protein always lacked the higher molecular weight bands, but consistently showed the four lower molecular weight bands to be well resolved. Taken together, these results imply that thrombin generates the FVIII procoagulant activity that is stabilized by 0.25 M CaCl2 and elutes aberrantly from 4% agarose in that solvent.
Mary Ellen Switzer, Patrick A. McKee
Title and authors | Publication | Year |
---|---|---|
Calcium Prevents Enhanced Degradation of Factor VIII in the Condition of Motion.
Cohen H, Keren-Politansky A, Crispel Y, Yanovich C, Asayag K, Nadir Y |
Biology | 2023 |
Application of a new statistical approach to optimize the immunopurification of antihemophilia A factor
N Bihoreau, S Layet, MP Fontaine-Aupart, P Paolantonacci |
Journal of Chromatography B: Biomedical Sciences and Applications | 1993 |
Advances in Human Genetics
H Harris, K Hirschhorn |
1990 | |
Factor VIII influences binding of factor IX and factor X to intact human platelets
W Muntean, B Leschnik |
Thrombosis Research | 1989 |
Factor VIII binds to von Willebrand factor via its Mr-80000 light chain
RJ HAMER, JA KOEDAM, NH BEESER-VISSER, JJ SIXMA, RM BERTINA, JA MOURIK |
European Journal of Biochemistry | 1987 |
The physiology and pathophysiology of the factor VIII complex
RJ Hamer, WP Houdijk, JJ Sixma, TW Barrowcliffe |
Critical Reviews in Oncology/Hematology | 1986 |
Binding of human thrombin to human factor VIII:RAg
L Hau, BG Firkin, MA Howard |
British Journal of Haematology | 1986 |
2. Rundtischgespräch Therapiebedingte Infektionen und Immundefekte bei Hämophilen
G Landbeck, R Marx |
1986 | |
Dissociation of the factor-VIII complex during clotting: role of thrombin and phospholipids
W Muntean, HJ Rothwangl |
European Journal of Clinical Investigation | 1984 |
The effect of carbohydrate depletion on procoagulant activity and in vivo survival of highly purified human factor VIII
PJ Fay, SI Chavin, JE Malone, D Schroeder, FE Young, VJ Marder |
Biochimica et Biophysica Acta (BBA) - General Subjects | 1984 |
Thrombosis and Cardiovascular Disease
A Strano |
1984 | |
Binding of native and thrombin activated factor VIII to platelets
K Sewerin, LO Andersson |
Thrombosis Research | 1983 |
New Comprehensive Biochemistry
S Yamamoto |
New Comprehensive Biochemistry | 1983 |
Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems
W Muntean, WE Hathaway, RR Montgomery |
British Journal of Haematology | 1982 |
OBSERVATIONS ON STRUCTURE-FUNCTION RELATIONSHIPS OF HUMAN ANTIHEMOPHILIC/VON WILLEBRAND FACTOR PROTEIN
PA McKee |
Annals of the New York Academy of Sciences | 1981 |
Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles
LO Andersson, JE Brown |
Biochemical Journal | 1981 |
Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF
CG Cockburn, RJ de Beaufre-Apps, J Wilson, RM Hardisty |
Thrombosis Research | 1981 |
Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction
RB Harris, J Newman, AJ Johnson |
Biochimica et Biophysica Acta (BBA) - Protein Structure | 1981 |
Ristocetin-induced aggregation of canine platelets
LA Leis, TK Rosborough, GS Johnson, GJ Johnson |
Thrombosis Research | 1980 |
Preparation and properties of bovine factor VIII (antihemophilic factor)
GA Vehar, EW Davie |
Biochemistry | 1980 |
Reactions of thrombin with human factor VIII/von Willebrande factor protein
ME Switzer, PA McKee |
The Journal of biological chemistry | 1980 |
Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues
JM Sodetz, JC Paulson, SV Pizzo, PA McKee |
The Journal of biological chemistry | 1978 |